Other Species / Isoforms
  PAG (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S50-p
EKKPRQHsGDHENLM
0 6
PAG (human) EKKPRQHsGDHENLM S50-p
PAG (mouse) EKKPRQHSGDHENLM S52
PAG (rat) DKKPRQHsGDHEsLM S52-p
N55
QHsGDHENLMNVPsD
0 1
PAG (human) QHsGDHENLMNVPsD N55
PAG (mouse) QHSGDHENLMNVPSD N57
PAG (rat) QHsGDHEsLMNVPsD S57-p
S61-p
ENLMNVPsDkEMFsR
0 11
PAG (human) ENLMNVPsDkEMFsR S61-p
PAG (mouse) ENLMNVPSDKDMFSH S63
PAG (rat) EsLMNVPsDKEMFSH S63-p
K63-ub
LMNVPsDkEMFsRsV
0 1
PAG (human) LMNVPsDkEMFsRsV K63-ub
PAG (mouse) LMNVPSDKDMFSHSA K65
PAG (rat) LMNVPsDKEMFSHSA K65
S67-p
PsDkEMFsRsVTsLA
0 1
PAG (human) PsDkEMFsRsVTsLA S67-p
PAG (mouse) PSDKDMFSHSATSLT S69
PAG (rat) PsDKEMFSHSATSLT S69
S69-p
DkEMFsRsVTsLATD
0 1
PAG (human) DkEMFsRsVTsLATD S69-p
PAG (mouse) DKDMFSHSATSLTTD S71
PAG (rat) DKEMFSHSATSLTTD S71
S72-p
MFsRsVTsLATDAPA
0 1
PAG (human) MFsRsVTsLATDAPA S72-p
PAG (mouse) MFSHSATSLTTDALA S74
PAG (rat) MFSHSATSLTTDALA S74
S80-p
LATDAPAsSEQNGAL
0 1
PAG (human) LATDAPAsSEQNGAL S80-p
PAG (mouse) LTTDALASSEQNGVL S82
PAG (rat) LTTDALASSEQNGVL S82
S97-p
GDILSEDstLTCMQH
0 1
PAG (human) GDILSEDstLTCMQH S97-p
PAG (mouse) GDILSEDSTLTCMQH S99
PAG (rat) GDILSEDSTMTCMQH S99
T98-p
DILSEDstLTCMQHy
0 1
PAG (human) DILSEDstLTCMQHy T98-p
PAG (mouse) DILSEDSTLTCMQHy T100
PAG (rat) DILSEDSTMTCMQHY T100
Y105-p
tLTCMQHyEEVQTSA
0 17
PAG (human) tLTCMQHyEEVQTSA Y105-p
PAG (mouse) TLTCMQHyEEVQTSA Y107-p
PAG (rat) TMTCMQHYEEVQTSA Y107
S150-p
DTMLTARsVDGDQGL
0 3
PAG (human) DTMLTARsVDGDQGL S150-p
PAG (mouse) DEILTARAADTELGP A152
PAG (rat) DAMLTARAADGDsGP A152
Q155
ARsVDGDQGLGMEGP
0 1
PAG (human) ARsVDGDQGLGMEGP Q155
PAG (mouse) ARAADTELGPGVEGP L157
PAG (rat) ARAADGDsGPGVEGP S157-p
Y163-p
GLGMEGPyEVLKDSs
Upstream
1 154
Treatment
  • anti-CD28
  • anti-CD3
  • ephrin_B1
  • gefitinib
PAG (human) GLGMEGPyEVLKDSs Y163-p
PAG (mouse) GPGVEGPyEVLKDss Y165-p
PAG (rat) GPGVEGPyEVLKDSS Y165-p
S169
PyEVLKDSssQENMV
0 1
PAG (human) PyEVLKDSssQENMV S169
PAG (mouse) PyEVLKDsssQENMV S171-p
PAG (rat) PyEVLKDSSSQENMV S171
S170-p
yEVLKDSssQENMVE
0 3
PAG (human) yEVLKDSssQENMVE S170-p
PAG (mouse) yEVLKDsssQENMVE S172-p
PAG (rat) yEVLKDSSSQENMVE S172
S171-p
EVLKDSssQENMVED
0 4
PAG (human) EVLKDSssQENMVED S171-p
PAG (mouse) EVLKDsssQENMVED S173-p
PAG (rat) EVLKDSSSQENMVED S173
Y181-p
NMVEDCLyEtVKEIK
Upstream
Downstream
2 133
Effects on Modified Protein
  • molecular association, regulation
Treatment
  • anti-CD28
  • anti-CD3
PAG (human) NMVEDCLyEtVKEIK Y181-p
PAG (mouse) NMVEDCLyETVKEIK Y183-p
PAG (rat) NMVEDCLyETVKEIK Y183-p
T183-p
VEDCLyEtVKEIKEV
0 1
PAG (human) VEDCLyEtVKEIKEV T183-p
PAG (mouse) VEDCLyETVKEIKEV T185
PAG (rat) VEDCLyETVKEIKEV T185
S206
GHSGKAKSTSASKEL
0 1
PAG (human) GHSGKAKSTSASKEL S206
PAG (mouse) GQGGKSKsTSALKEL S203-p
PAG (rat) SQGGKSKSTSALKEL S203
Y227-p
GKAEFAEyAsVDRNK
Upstream
0 309
Treatment
  • anti-CD28
  • anti-CD3
  • ephrin_B1
  • ephrin_B2
PAG (human) GKAEFAEyAsVDRNK Y227-p
PAG (mouse) GKADFAEyASVDRNK Y224-p
PAG (rat) GKADFAEyASVDRNK Y224-p
S229-p
AEFAEyAsVDRNKKC
0 18
PAG (human) AEFAEyAsVDRNKKC S229-p
PAG (mouse) ADFAEyASVDRNKKC S226
PAG (rat) ADFAEyASVDRNKKC S226
S239-p
RNKKCRQsVNVESIL
0 4
PAG (human) RNKKCRQsVNVESIL S239-p
PAG (mouse) RNKKCRHsANAESIL S236-p
PAG (rat) RNKKCRHSTNAESIL S236
C250
ESILGNSCDPEEEAP
0 4
PAG (human) ESILGNSCDPEEEAP C250
PAG (mouse) ESILGTCsDLDEEsP S247-p
PAG (rat) ESILGTSsDLDEETP S247-p
A256
SCDPEEEAPPPVPVK
0 3
PAG (human) SCDPEEEAPPPVPVK A256
PAG (mouse) CsDLDEEsPPPVPVK S253-p
PAG (rat) SsDLDEETPPPVPVK T253
T287
EESATDTTsETNKRF
0 1
PAG (human) EESATDTTsETNKRF T287
PAG (mouse) EEQAAEGtGGHsKRF T284-p
PAG (rat) EEQAPEAPSGHSKRF P284
S288-p
ESATDTTsETNKRFs
0 1
PAG (human) ESATDTTsETNKRFs S288-p
PAG (mouse) EQAAEGtGGHsKRFs G285
PAG (rat) EQAPEAPSGHSKRFs S285
N291
TDTTsETNKRFssLs
0 1
PAG (human) TDTTsETNKRFssLs N291
PAG (mouse) AEGtGGHsKRFssLs S288-p
PAG (rat) PEAPSGHSKRFssLS S288
S295-p
sETNKRFssLsyKsR
Upstream
0 11
Treatment
  • angiotensin_2
  • SII_angiotensin_2
PAG (human) sETNKRFssLsyKsR S295-p
PAG (mouse) GGHsKRFssLsYKSR S292-p
PAG (rat) SGHSKRFssLSYKSR S292-p
S296-p
ETNKRFssLsyKsRE
0 15
PAG (human) ETNKRFssLsyKsRE S296-p
PAG (mouse) GHsKRFssLsYKSRE S293-p
PAG (rat) GHSKRFssLSYKSRE S293-p
S298-p
NKRFssLsyKsREED
Upstream
0 12
Treatment
  • angiotensin_2
  • SII_angiotensin_2
PAG (human) NKRFssLsyKsREED S298-p
PAG (mouse) sKRFssLsYKSREED S295-p
PAG (rat) SKRFssLSYKSREED S295
Y299-p
KRFssLsyKsREEDP
Downstream
1 0
Effects on Modified Protein
  • molecular association, regulation
PAG (human) KRFssLsyKsREEDP Y299-p
PAG (mouse) KRFssLsYKSREEDP Y296
PAG (rat) KRFssLSYKSREEDP Y296
S301-p
FssLsyKsREEDPtL
0 2
PAG (human) FssLsyKsREEDPtL S301-p
PAG (mouse) FssLsYKSREEDPTL S298
PAG (rat) FssLSYKSREEDPTL S298
T307-p
KsREEDPtLTEEEIs
0 2
PAG (human) KsREEDPtLTEEEIs T307-p
PAG (mouse) KSREEDPTLTEEEIS T304
PAG (rat) KSREEDPTLTEEEIS T304
S314-p
tLTEEEIsAMyssVN
0 6
PAG (human) tLTEEEIsAMyssVN S314-p
PAG (mouse) TLTEEEISAMySSVN S311
PAG (rat) TLTEEEISAMysSVN S311
Y317-p
EEEIsAMyssVNKPG
Upstream
Downstream
9 664
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • apoptosis, inhibited
  • carcinogenesis, induced
  • cell growth, induced
Putative in vivo kinases:
  • Fyn (human)
  • Src (human)
Putative upstream phosphatases:
  • PTP1B (human)
Treatment
  • anti-CD28
  • anti-CD3
  • CGP76030
  • ephrin_B1
  • gefitinib
  • phorbol_ester
PAG (human) EEEIsAMyssVNKPG Y317-p
PAG (mouse) EEEISAMySSVNKPG Y314-p
PAG (rat) EEEISAMysSVNKPG Y314-p
S318-p
EEIsAMyssVNKPGQ
0 68
PAG (human) EEIsAMyssVNKPGQ S318-p
PAG (mouse) EEISAMySSVNKPGQ S315
PAG (rat) EEISAMysSVNKPGQ S315-p
S319-p
EIsAMyssVNKPGQL
0 2
PAG (human) EIsAMyssVNKPGQL S319-p
PAG (mouse) EISAMySSVNKPGQS S316
PAG (rat) EISAMysSVNKPGQs S316
L326
sVNKPGQLVNKSGQS
0 1
PAG (human) sVNKPGQLVNKSGQS L326
PAG (mouse) SVNKPGQSAHKPGPC S323
PAG (rat) SVNKPGQsAHKPGPE S323-p
S339-p
QSLTVPEstytsIQG
0 12
PAG (human) QSLTVPEstytsIQG S339-p
PAG (mouse) PCMKGPESACHsMKG S336
PAG (rat) AHKPGPESTCQCPQG S331
T340-p
SLTVPEstytsIQGD
0 14
PAG (human) SLTVPEstytsIQGD T340-p
PAG (mouse) CMKGPESACHsMKGL A337
PAG (rat) HKPGPESTCQCPQGP T332
Y341-p
LTVPEstytsIQGDP
Upstream
0 496
Treatment
  • anti-CD28
  • anti-CD3
  • ephrin_B1
  • ephrin_B2
  • erlotinib
PAG (human) LTVPEstytsIQGDP Y341-p
PAG (mouse) MKGPESACHsMKGLP C338
PAG (rat) KPGPESTCQCPQGPP C333
T342-p
TVPEstytsIQGDPQ
0 1
PAG (human) TVPEstytsIQGDPQ T342-p
PAG (mouse) KGPESACHsMKGLPQ H339
PAG (rat) PGPESTCQCPQGPPQ Q334
S343-p
VPEstytsIQGDPQR
0 3
PAG (human) VPEstytsIQGDPQR S343-p
PAG (mouse) GPESACHsMKGLPQR S340-p
PAG (rat) GPESTCQCPQGPPQR C335
S351-p
IQGDPQRsPssCNDL
0 2
PAG (human) IQGDPQRsPssCNDL S351-p
PAG (mouse) MKGLPQRSSSsCNDL S348
PAG (rat) PQGPPQRSSSsCNDL S343
S353-p
GDPQRsPssCNDLyA
Upstream
0 2
Regulatory protein:
  • ZAP70 (human)
PAG (human) GDPQRsPssCNDLyA S353-p
PAG (mouse) GLPQRSSSsCNDLyA S350
PAG (rat) GPPQRSSSsCNDLyA S345
S354-p
DPQRsPssCNDLyAt
0 37
PAG (human) DPQRsPssCNDLyAt S354-p
PAG (mouse) LPQRSSSsCNDLyAt S351-p
PAG (rat) PPQRSSSsCNDLyAT S346-p
Y359-p
PssCNDLyAtVKDFE
Upstream
0 623
Regulatory protein:
  • ZAP70 (human)
Treatment
  • ephrin_B1
  • ephrin_B2
  • erlotinib
  • gefitinib
PAG (human) PssCNDLyAtVKDFE Y359-p
PAG (mouse) SSsCNDLyAtVKDFE Y356-p
PAG (rat) SSsCNDLyATVKDFE Y351-p
T361-p
sCNDLyAtVKDFEKT
0 4
PAG (human) sCNDLyAtVKDFEKT T361-p
PAG (mouse) sCNDLyAtVKDFEKT T358-p
PAG (rat) sCNDLyATVKDFEKT T353
S380-p
LPPAGRPsEEPEPDy
0 23
PAG (human) LPPAGRPsEEPEPDy S380-p
PAG (mouse) LPPARRPsEEPEPDy S379-p
PAG (rat) LPPARRPGEEPEPDy G374
Y387-p
sEEPEPDyEAIQtLN
Upstream
3 104
Treatment
  • anti-CD28
  • anti-CD3
  • gefitinib
PAG (human) sEEPEPDyEAIQtLN Y387-p
PAG (mouse) sEEPEPDyEAIQTLN Y386-p
PAG (rat) GEEPEPDyEAIQTLN Y381-p
T392-p
PDyEAIQtLNREEEK
0 2
PAG (human) PDyEAIQtLNREEEK T392-p
PAG (mouse) PDyEAIQTLNREDEK T391
PAG (rat) PDyEAIQTLNREDDK T386
T404-p
EEKATLGtNGHHGLV
0 3
PAG (human) EEKATLGtNGHHGLV T404-p
PAG (mouse) DEKVPLETNGHHVPK T403
PAG (rat) DDKVPLGTNGHLVPK T398
N415
HGLVPKENDyEsIsD
0 1
PAG (human) HGLVPKENDyEsIsD N415
PAG (mouse) GHHVPKEsDyEsIGD S412-p
PAG (rat) GHLVPKENDyESIGD N407
Y417-p
LVPKENDyEsIsDLQ
Upstream
3 690
Regulatory protein:
  • EGFR (human)
Treatment
  • anti-CD28
  • anti-CD3
  • ephrin_B1
  • ephrin_B2
  • gefitinib
  • U0126
PAG (human) LVPKENDyEsIsDLQ Y417-p
PAG (mouse) HVPKEsDyEsIGDLQ Y414-p
PAG (rat) LVPKENDyESIGDLQ Y409-p
S419-p
PKENDyEsIsDLQQG
0 19
PAG (human) PKENDyEsIsDLQQG S419-p
PAG (mouse) PKEsDyEsIGDLQQC S416-p
PAG (rat) PKENDyESIGDLQQG S411
S421-p
ENDyEsIsDLQQGRD
0 1
PAG (human) ENDyEsIsDLQQGRD S421-p
PAG (mouse) EsDyEsIGDLQQCRD G418
PAG (rat) ENDyESIGDLQQGRD G413